Abciximab and rt-PA in Acute Ischemic Stroke Treatment

Completed

Phase N/A Results

Summary of Purpose

To evaluate the safety and potential benefits and abciximab administered in conjunction with half-dose rt-PA in acute ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institute of Neurological Disorders and Stroke - NIH

Trial Design

Single-center, open-label, phase I, safety and efficacy study.

Contacts

Not available